 |
|
Refine By Categories
Regulatory Processes
Diseases
Protein Regulatory Pathways
|
 |
|
 |
|
|
Results
|
|
|
 |
| Showing 21 - 28 out of 28 |
Result pages:
Prev 1 2 3 |
|
Development_Endothelin-1/EDNRA signaling [score: 1 (0%)]
Endothelin-1, a potent endothelium-derived
vasoconstrictor peptide, exerts a growth-promoting effect on vascular smooth muscle
cells, implicating its pathogenic role in vascular remodeling.
Endothelin-1 action is exerted by its binding to Endothelin
receptor type A (EDNRA) [
Development_EDNRB signaling [score: 1 (0%)]
Endothelin receptor type B (EDNRB) belongs to the guanine
nucleotide binding protein (G-protein) coupled receptor family.
Endothelin-1 is most investigated physiological ligand of
EDNRB [1]. EDNRB
binds to many types of the G-proteins but the ...
Apoptosis and survival_Role of CDK5 in neuronal death and survival [score: 1 (0%)]
Cyclin-dependent kinase 5 (CDK5) is a member of the small
serine/threonine cyclin-dependent kinase (CDK) family.
The best known role of CDK5 is its regulatoin of the
cytoskeleton architecture of the central nervous system (CNS). There is also some
evidence that links CDK5 ...
Development_Activation of ERK by Alpha-1 adrenergic receptors [score: 1 (0%)]
Subtype alpha-1 adrenergic receptors consists of Alpha-1A adrenergic
receptor, Alpha-1B adrenergic receptor and
Alpha-1D adrenergic receptor. They participate in many
physiological processes via different pathways. One of the best studied alpha-1
adrenergic receptors-stimulated ...
Mucin expression in CF via TLRs, EGFR signaling pathways [score: 1 (0%)]
Cystic Fibrosis (CF) is a potentially lethal genetic disease that typically results in
the development of bronchial inflammation, bronchiectasis, the progressive loss of lung
function and ultimately death [1].
CF was initially called "mucoviscidosis" because of ...
Angiotensin activation of ERK [score: 1 (0%)]
Angiotensin II, a major effector peptide of the
renin-angiotensin system, and is believed to play a critical role in the pathogenesis of
cardiovascular remodeling associated with hypertension, heart failure, and
atherosclerosis [1]. Angiotensin II acts via
Angiotensin ...
|
|
|
|
|